VALBIOTIS: 2021 Financial Communication Calendar Regulatory News: VALBIOTIS (Paris:ALVAL) (FR0013254851 ALVAL eligible for the PEA/SME), a Research Development company committed to scientific innovation for preventing and combating metabolic diseases, today presents its 2021 financial communication calendar. March, 17: Annual Report (after market closing) May, 27: General Meeting (terms of participation to be specified later) September, 30: Half-year Report (after market closing) ABOUT VALBIOTIS VALBIOTIS is a Research Development company committed to scientific innovation for preventing and combating metabolic diseases in response to unmet medical needs. VALBIOTIS has adopted an innovative approach, aiming to revolutionize healthcare by developing a new class of nutritional health solutions designed to reduce the risk of major metabolic diseases, based on a multi-target approach and made possible by the use of plant-based ingredients.